238120 — Aligned Genetics Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapSuper Stock

Annual cashflow statement for Aligned Genetics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	468	5,542	2,333	3,236	4,128
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	-231	-1,300	966	841	-819
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-877	-2,873	-1,876	-1,909	-863
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	35.7	136	2,222	2,849	3,065
Capital Expenditures	-106	-202	-1,869	-880	-340
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	1,271	-3,466	4,406	2,171	-7,205
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	1,166	-3,668	2,537	1,290	-7,545
Net Issuance / Retirement of Debt
Cash from Financing Activities	-228	3,633	-176	-193	-1,730
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	741	498	4,559	4,231	-4,788